Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Highbridge Capital Management
Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Highbridge Capital Management
from 13F filings
Historical chart of Highbridge Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Highbridge Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $33M | 37M | 0.88 |
| 2025-06-30 | $30M | 40M | 0.74 |
| 2025-03-31 | $35M | 38M | 0.93 |
| 2024-12-31 | $63M | 58M | 1.10 |
| 2024-09-30 | $68M | 60M | 1.14 |
| 2024-06-30 | $58M | 45M | 1.29 |
| 2023-12-31 | $51B | 50M | 1015.44 |
| 2023-09-30 | $35M | 31M | 1.12 |
More positions owned by Highbridge Capital Management
View all positions for Highbridge Capital Management
Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1
View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1